Recent 8-K filings for AMTX
Highest-materiality recent filing
Aemetis Biogas extends $114.7M preferred unit redemption to April 30, 2026; credit agreement triggers if missed
- Redemption deadline moved from Dec 31, 2025 to Apr 30, 2026; price set at $114.7M including a $2M fee.
- If not redeemed, ABGL enters a credit agreement with Protair-X and Third Eye Capital: $114.7M principal, due May 1, 2027.
-
Aemetis Q1 revenue up 27% to $54.6M; gross profit turns positive; RNG volumes up 55%
Revenue $54.6M (+27% YoY); gross profit $2.8M vs gross loss $5.1M in Q1 2025
-
Aemetis Q4 2025 net loss narrows to $5.3M; biogas net income $12.2M, dairy RNG up 61% YoY
Q4 2025 revenue + PTCs $53.7M, up from $47.0M YoY; full-year $208.0M vs $268M (lower ethanol/India biodiesel).
-
Aemetis shareholders approve increase in authorized common stock; preferred stock decrease fails
Shareholders approved amendment to increase authorized common stock from 80M to 140M shares at Feb 18, 2026 special meeting.
-
Redemption deadline moved from Dec 31, 2025 to Apr 30, 2026; price set at $114.7M including a $2M fee.
-
Aemetis authorizes $80M stock buyback; approves executive bonuses and $350K CEO guarantee fee
Board authorized up to $80M share repurchase of common stock; open market or private; no expiration date.
-
Aemetis Q3 2025 revenue $59.2M, net loss $23.7M; MVR system contract signed
Revenue $59.2M, up $7M from Q2 2025, driven by India OMC orders and stronger ethanol.
-
Aemetis extends biogas unit's $118.8M preferred unit redemption deadline; faces 16%+ credit if unmet
ABGL extends redemption of Protair-X's Series A Preferred Units from Aug 31, 2025 to Dec 31, 2025.
-
Aemetis Q2 2025 revenue $52.2M, net loss $23.4M; India subsidiary IPO targeted early 2026
Revenue $52.2M, up $9.3M from Q1 2025; gross loss $3.4M vs $1.8M loss a year ago.
-
Aemetis Q1 revenue falls 41% to $42.9M; net loss $24.5M; India biodiesel LOIs $31M
Revenue of $42.9M vs $72.6M YoY, driven by India OMC contract delays; Keyes ethanol plant revenue up $1.7M on higher prices.
-
Aemetis FY2024 revenue $268M (+43% YoY); net loss more than doubles to $87.5M
Annual revenues grew 43% to $268M driven by all segments: ethanol +55%, India biodiesel +20%, biogas +139%.
-
Aemetis extends maturity of $136M in notes one year to April 2026 via written notice
Subsidiaries notified Third Eye Capital to extend maturity from Apr 1, 2025 to Apr 1, 2026.
-
Aemetis (AMTX) amends ATM agreement to sell up to $210M in common stock
Aemetis may sell up to $210M of common stock through an at-the-market offering via H.C. Wainwright at market prices.
-
Aemetis Q3 2024 revenues up 19% YoY to $81.4M; net loss widens to $17.9M
Net loss of $17.9M vs net income of $30.7M in Q3 2023; operating loss improved to $3.9M from $8.5M.
-
Aemetis Q2 2024 revenue up 48% to $66.6M; net loss widens to $29.2M
Q2 2024 revenue $66.6M (+48% YoY): California Ethanol $40.1M, India Biodiesel $28.8M, Dairy RNG $1.6M from 89,400 MMBtu.
-
Aemetis reports Q1 revenue $72.6M, up from $2.2M; net loss $24.2M vs $26.4M
Revenue $72.6M (Q1 2023: $2.2M) driven by Keyes plant restart and dairy RNG + India biodiesel.
Earnings & guidance
Materiality & sentiment trend
Max materiality 0.80 · Median 0.70 · Most common event earnings